Pilomatrix carcinoma: 13 new cases and review of the literature with emphasis on predictors of metastasis.

J Am Acad Dermatol

Dermatology, Michigan State University College of Osteopathic Medicine, East Lansing, Michigan; Pathology, University of South Florida Morsani College of Medicine, Tampa, Florida; and Dermpath Diagnostics in Tampa, Pensacola, and Marietta, Georgia.

Published: July 2014

Background: Pilomatrix carcinoma is a rare cutaneous tumor derived from follicular matrix cells with few cases documented in the literature.

Objective: We sought to better characterize this tumor by analyzing its epidemiologic, clinical, and histopathologic features in 13 new cases and by reviewing the literature.

Methods: All cases of pilomatrix carcinoma from a large regional dermatopathology practice were identified and analyzed by chart review for clinical and histopathologic characteristics. Similar characteristics were compiled from an additional 123 cases in the English-language literature. Cox proportional hazards regression models were used to determine risk factors associated with the development of metastasis for all identified metastatic tumors.

Results: Our 13 tumors were most common in middle-aged to older white men and presented mostly on the head/neck. Histopathologically, tumors were asymmetric, were poorly circumscribed, were composed of basaloid and "ghost" cells, had frequent atypical mitoses, and had infrequent lymphovascular invasion. Wide excision was considered the most definitive treatment modality, but local recurrence was common. When analyzing all reported cases of metastasis using statistics, metastasis was significantly associated (hazard ratio 3.45, P < .0413) with local tumor recurrence.

Limitations: The retrospective, single-center design and the reliance on electronic medical records are limitations.

Conclusions: This study helps better characterize pilomatrix carcinoma and identifies potential predictors of metastasis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2014.02.042DOI Listing

Publication Analysis

Top Keywords

pilomatrix carcinoma
16
predictors metastasis
8
better characterize
8
clinical histopathologic
8
cases
6
metastasis
5
pilomatrix
4
carcinoma cases
4
cases review
4
review literature
4

Similar Publications

Pilomatrix carcinoma (PC) is a rare malignant adnexal tumor originating from follicular matrix cells primarily impacting Caucasian males. This review provides a comprehensive analysis of scientific literature on PC through an exploration of 206 cases reported between 1980 and 2024. We discuss the epidemiology, clinical presentation, histopathology, and diagnostic challenges of PC, and explore various treatment methods for this rare malignancy as well as their associated outcomes.

View Article and Find Full Text PDF

A 63-year-old man, with no past medical history, presented with an asymptomatic, progressively evolving polypoid lesion for 2 years in the left ciliary region. Physical examination revealed an exophytic tumor lesion of firm consistency and lobulated surface, with regular and well-defined borders. It measured 2 cm in diameter, and had a brownish-violet coloration with whitish areas (Figure 1).

View Article and Find Full Text PDF
Article Synopsis
  • Pilomatrix carcinoma (PMC) is a rare and aggressive hair follicle tumor with high recurrence and metastasis risks, often stemming from benign pilomatricoma or arising independently.
  • A study analyzed various surgical treatments for PMC by reviewing 257 articles from major databases, ultimately including 50 relevant studies, highlighting the effectiveness of different surgical methods.
  • The findings revealed that Mohs micrographic surgery (MMS) had no recurrences in 17 treated cases, while surgical excision resulted in a 34.5% recurrence rate, suggesting that MMS is a superior option to minimize recurrence and preserve tissue.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!